AGX
Argan Inc
364.30$
+0.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +6.1% | +4.4% | +16.4% | +5.8% | +8.8% | -5.3% | +11.4% | +19.1% | +12.9% | +8.6% | +8.8% | |
| – | +6.4% | +5.0% | +17.5% | +6.3% | +8.9% | -5.5% | +12.3% | +20.3% | +13.5% | +7.4% | +8.4% | |
| – | +6.2% | +5.4% | +12.0% | -24.6% | -17.2% | +30.3% | -6.0% | +72.2% | +10.8% | +4.8% | +2.4% | |
| – | +3.7% | +1.0% | +16.4% | +4.5% | +3.7% | +4.1% | +4.7% | +27.0% | +23.1% | +8.8% | +5.6% | |
| – | +26.8% | +38.8% | +20.4% | +22.2% | +23.0% | -28.2% | +39.9% | -11.5% | -0.1% | -4.5% | -11.4% | |
| – | -19.8% | -4.1% | -14.2% | -58.1% | -90.7% | +268.1% | +6.6% | +438.1% | +62.4% | +11.1% | +7.7% | |
| – | – | – | – | – | +19.5% | -0.8% | -0.2% | -0.5% | +2.0% | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +9.4% | |
| – | -4.2% | -4.4% | -4.6% | -4.8% | -5.1% | -5.4% | -5.7% | -6.0% | -5.4% | -5.2% | +338.5% | |
| – | +10.2% | +7.8% | +26.3% | +5.2% | +10.0% | -11.6% | +14.3% | +28.9% | +14.7% | +12.3% | +10.0% | |
| – | +10.4% | +8.4% | +26.7% | +5.1% | +10.0% | -11.9% | +14.5% | +28.0% | +14.0% | +12.5% | +10.5% | |
| – | +88.4% | +20.4% | +12.6% | -28.4% | +2.3% | -1.2% | -11.2% | +10.4% | -4.2% | – | – | |
| – | +14.3% | +68.3% | +50.0% | -12.6% | +11.7% | -28.8% | +38.7% | +4.9% | +6.7% | +15.2% | -7.0% | |
| – | +2.1% | +0.8% | +5.1% | +6.7% | +7.0% | +3.4% | +8.0% | +6.7% | +10.1% | +2.4% | +7.0% | |
| – | +3.7% | +1.7% | +6.2% | +9.4% | +9.9% | +6.0% | +9.7% | +7.0% | +11.6% | +9.6% | +10.4% | |
| – | -0.1% | +0.2% | +2.3% | +1.1% | +0.7% | -0.2% | +0.1% | +0.2% | +0.2% | +0.1% | -0.2% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.